11 – 15 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2017
-
Mark
Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine
Urey, Carlos LU ; Andersson, Bodil LU
; Ansari, Daniel
LU
; Sasor, Agata
; Said-Hilmersson, Katarzyna
LU
; Nilsson, Johan
LU
and Andersson, Roland
LU
(2017)
In Scandinavian Journal of Gastroenterology
52(5).
p.595-600
- Contribution to journal › Article
-
Mark
Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma
Ansari, D. LU ; Bauden, M. LU
; Bergström, S.
LU
; Rylance, R.
LU
; Marko-Varga, G.
LU
and Andersson, R.
LU
(2017)
In British Journal of Surgery
104(5).
p.600-607
- Contribution to journal › Article
-
Mark
Development and In Vitro Characterization of a Gemcitabine-loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma
Urey, Carlos LU ; Hilmersson, Katarzyma Said LU ; Andersson, Bodil LU
; Ansari, Daniel
LU
and Andersson, Roland
LU
(2017)
In Anticancer research
37(11).
p.6031-6039
- Contribution to journal › Article
-
Mark
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma
Bauden, Monika LU
; Kristl, Theresa
LU
; Sasor, Agata
; Andersson, Bodil
LU
; Marko-Varga, György
LU
; Andersson, Roland
LU
and Ansari, Daniel
LU
(2017)
In BMC Cancer
17(1).
- Contribution to journal › Article
- 2007
-
Mark
Predictive factors in pancreatic ductal adenocarcinoma: Role of the inflammatory response.
Tingstedt, Bobby LU ; Johansson, Patrik ; Andersson, Bodil LU
and Andersson, Roland
LU
(2007)
In Scandinavian Journal of Gastroenterology
42(6).
p.754-759
- Contribution to journal › Article
- « previous
- 1
- 2
- next »